Kronos Bio Ownership 2024 | Who Owns Kronos Bio Now?
Institutional Ownership
13.79%
Insider Ownership
26.90%
Retail Ownership
59.31%
Institutional Holders
16.00
Kronos Bio Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| VIDA VENTURES ADVISORS, LLC | 4.65% | 3.75% | 2,765,314 | - | - | 3,428,989 | Jun 30, 2024 |
| VANGUARD GROUP INC | 3.23% | - | 1,922,809 | -25,786 | -1.32% | 2,384,283 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 3.12% | 0.00% | 1,857,988 | 30,265 | 1.66% | 2,303,905 | Jun 30, 2024 |
| PARTNERS CAPITAL INVESTMENT GROUP, LLP | 2.80% | 0.03% | 1,665,797 | 1,138,297 | 215.79% | 2,044,488 | Jun 30, 2024 |
| ALPHABET INC. | 2.42% | 0.09% | 1,438,232 | - | - | 1,783,408 | Jun 30, 2024 |
| WILDCAT CAPITAL MANAGEMENT, LLC | 2.18% | 0.39% | 1,297,959 | - | - | 1,609,469 | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 2.07% | 0.00% | 1,229,910 | 455,351 | 58.79% | 1,524,000 | Jun 30, 2024 |
| MARINER, LLC | 1.75% | 0.00% | 1,041,031 | 962,231 | 1221.11% | 1,290,878 | Jun 30, 2024 |
| BLACKROCK INC. | 1.47% | - | 874,102 | -35,348 | -3.89% | 1,083,888 | Jun 30, 2024 |
| ARTAL GROUP S.A. | 1.42% | 0.03% | 842,954 | - | - | 1,045,263 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 1.28% | 0.00% | 764,126 | -267,404 | -25.92% | 947,516 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.77% | - | 459,288 | 18,063 | 4.09% | 569,663 | Jun 30, 2024 |
| ACUITAS INVESTMENTS, LLC | 0.74% | 0.29% | 443,457 | 2,351 | 0.53% | 549,887 | Jun 30, 2024 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 0.74% | 0.00% | 440,737 | 381,339 | 642.01% | 546,514 | Jun 30, 2024 |
| CERITY PARTNERS LLC | 0.69% | 0.00% | 410,796 | - | - | 509,387 | Jun 30, 2024 |
| CHOATE INVESTMENT ADVISORS | 0.52% | 0.01% | 308,697 | - | - | 382,784 | Jun 30, 2024 |
| GENTRUST, LLC | 0.50% | 0.02% | 295,246 | 295,246 | 100.00% | 366,105 | Jun 30, 2024 |
| PRIVIUM FUND MANAGEMENT (UK) LTD | 0.49% | 0.13% | 292,182 | - | - | 341,853 | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.34% | 0.01% | 199,702 | -115,300 | -36.60% | 247,630 | Jun 30, 2024 |
| STATE STREET CORP | 0.29% | - | 175,301 | -3,000 | -1.68% | 217,373,000 | Jun 30, 2024 |
Kronos Bio's largest institutional shareholder is VIDA VENTURES ADVISORS, LLC, holding 4.65% of the company's total share outstanding, currently valued at $3.43M. The top 10 institutional shareholders own together 25.09% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| VIDA VENTURES ADVISORS, LLC | 4.65% | 3.75% | 2,765,314 | - | - | 3,428,989 | Jun 30, 2024 |
| WILDCAT CAPITAL MANAGEMENT, LLC | 2.18% | 0.39% | 1,297,959 | - | - | 1,609,469 | Jun 30, 2024 |
| ACUITAS INVESTMENTS, LLC | 0.74% | 0.29% | 443,457 | 2,351 | 0.53% | 549,887 | Jun 30, 2024 |
| CM MANAGEMENT, LLC | 0.23% | 0.15% | 135,000 | -115,000 | -46.00% | 167,400 | Jun 30, 2024 |
| PRIVIUM FUND MANAGEMENT (UK) LTD | 0.49% | 0.13% | 292,182 | - | - | 341,853 | Jun 30, 2024 |
| ALPHABET INC. | 2.42% | 0.09% | 1,438,232 | - | - | 1,783,408 | Jun 30, 2024 |
| FOREFRONT ANALYTICS, LLC | 0.23% | 0.08% | 134,998 | 57,867 | 75.02% | 167,400 | Jun 30, 2024 |
| PARTNERS CAPITAL INVESTMENT GROUP, LLP | 2.80% | 0.03% | 1,665,797 | 1,138,297 | 215.79% | 2,044,488 | Jun 30, 2024 |
| ARTAL GROUP S.A. | 1.42% | 0.03% | 842,954 | - | - | 1,045,263 | Jun 30, 2024 |
| 0.03% | 0.02% | 15,718 | 15,718 | 100.00% | 19,490 | Jun 30, 2024 | |
| SAMSARA BIOCAPITAL, LLC | 0.13% | 0.02% | 78,131 | - | - | 96,882 | Jun 30, 2024 |
| GENTRUST, LLC | 0.50% | 0.02% | 295,246 | 295,246 | 100.00% | 366,105 | Jun 30, 2024 |
| MARQUETTE ASSET MANAGEMENT, LLC | 0.14% | 0.02% | 80,369 | - | - | 99,658 | Jun 30, 2024 |
| COASTAL BRIDGE ADVISORS, LLC | 0.09% | 0.02% | 51,968 | - | - | 64,440 | Jun 30, 2024 |
| CASDIN CAPITAL, LLC | 0.21% | 0.01% | 123,839 | - | - | 153,560 | Jun 30, 2024 |
| CHOATE INVESTMENT ADVISORS | 0.52% | 0.01% | 308,697 | - | - | 382,784 | Jun 30, 2024 |
| CORNERCAP INVESTMENT COUNSEL INC | 0.07% | 0.01% | 40,208 | -1,143 | -2.76% | 49,858 | Jun 30, 2024 |
| DAKOTA COMMUNITY BANK & TRUST NA | 0.00% | 0.01% | 943 | - | - | 1,169 | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.34% | 0.01% | 199,702 | -115,300 | -36.60% | 247,630 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.08% | 0.01% | 49,911 | 9,096 | 22.29% | 61,890 | Jun 30, 2024 |
The largest Kronos Bio shareholder by % of total assets is VIDA VENTURES ADVISORS, LLC. The company owns 2.77M shares of Kronos Bio (KRON), representing 3.75% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| PARTNERS CAPITAL INVESTMENT GROUP, LLP | 2.80% | 0.03% | 1,665,797 | 1,138,297 | 215.79% | 2,044,488 | Jun 30, 2024 |
| MARINER, LLC | 1.75% | 0.00% | 1,041,031 | 962,231 | 1221.11% | 1,290,878 | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 2.07% | 0.00% | 1,229,910 | 455,351 | 58.79% | 1,524,000 | Jun 30, 2024 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 0.74% | 0.00% | 440,737 | 381,339 | 642.01% | 546,514 | Jun 30, 2024 |
| GENTRUST, LLC | 0.50% | 0.02% | 295,246 | 295,246 | 100.00% | 366,105 | Jun 30, 2024 |
| INTEGRATED WEALTH CONCEPTS LLC | 0.12% | 0.00% | 71,551 | 71,551 | 100.00% | 88,723 | Jun 30, 2024 |
| FOREFRONT ANALYTICS, LLC | 0.23% | 0.08% | 134,998 | 57,867 | 75.02% | 167,400 | Jun 30, 2024 |
| PRUDENTIAL FINANCIAL INC | 0.09% | 0.00% | 55,800 | 55,800 | 100.00% | 69,192 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 3.12% | 0.00% | 1,857,988 | 30,265 | 1.66% | 2,303,905 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.77% | - | 459,288 | 18,063 | 4.09% | 569,663 | Jun 30, 2024 |
| 0.03% | 0.02% | 15,718 | 15,718 | 100.00% | 19,490 | Jun 30, 2024 | |
| NATIONAL BANK OF CANADA /FI/ | 0.03% | - | 15,000 | 15,000 | 100.00% | 16,800 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.08% | 0.01% | 49,911 | 9,096 | 22.29% | 61,890 | Jun 30, 2024 |
| KENNEDY CAPITAL MANAGEMENT LLC | 0.20% | 0.00% | 117,637 | 2,576 | 2.24% | 145,870 | Jun 30, 2024 |
| ACUITAS INVESTMENTS, LLC | 0.74% | 0.29% | 443,457 | 2,351 | 0.53% | 549,887 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.01% | - | 6,123 | 379 | 6.60% | 7,592 | Jun 30, 2024 |
| PATHSTONE HOLDINGS, LLC | 0.02% | 0.00% | 12,034 | 50 | 0.42% | 14,922 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 0.00% | - | 350 | - | - | 434 | Jun 30, 2024 |
| FMR LLC | 0.01% | - | 3,200 | - | - | 3,968 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.00% | - | 297 | - | - | 368 | Jun 30, 2024 |
As of Jun 30 2024, Kronos Bio's largest institutional buyer is PARTNERS CAPITAL INVESTMENT GROUP, LLP. The company purchased 1.14M stocks of KRON, valued at $2.04M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BVF INC/IL | - | - | - | -2,905,043 | -100.00% | - | Jun 30, 2024 |
| OMEGA FUND MANAGEMENT, LLC | - | - | - | -955,866 | -100.00% | - | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 1.28% | 0.00% | 764,126 | -267,404 | -25.92% | 947,516 | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.34% | 0.01% | 199,702 | -115,300 | -36.60% | 247,630 | Jun 30, 2024 |
| CM MANAGEMENT, LLC | 0.23% | 0.15% | 135,000 | -115,000 | -46.00% | 167,400 | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | - | - | - | -107,754 | -100.00% | - | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | - | - | - | -57,347 | -100.00% | - | Jun 30, 2024 |
| VIRTU FINANCIAL LLC | - | - | - | -54,592 | -100.00% | - | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.14% | 0.00% | 81,380 | -50,940 | -38.50% | 100,911 | Jun 30, 2024 |
| BLACKROCK INC. | 1.47% | - | 874,102 | -35,348 | -3.89% | 1,083,888 | Jun 30, 2024 |
| VANGUARD GROUP INC | 3.23% | - | 1,922,809 | -25,786 | -1.32% | 2,384,283 | Jun 30, 2024 |
| UBS GROUP AG | - | - | - | -20,645 | -100.00% | - | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | - | - | - | -12,246 | -100.00% | - | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 0.03% | 0.00% | 20,174 | -10,117 | -33.40% | 25,016 | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 0.01% | 0.00% | 5,540 | -9,649 | -63.53% | 6,870 | Jun 30, 2024 |
| SIMPLEX TRADING, LLC | 0.00% | - | 2,030 | -3,160 | -60.89% | 2,000 | Jun 30, 2024 |
| STATE STREET CORP | 0.29% | - | 175,301 | -3,000 | -1.68% | 217,373,000 | Jun 30, 2024 |
| CORNERCAP INVESTMENT COUNSEL INC | 0.07% | 0.01% | 40,208 | -1,143 | -2.76% | 49,858 | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | - | - | - | -347 | -100.00% | - | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.03% | - | 17,785 | -110 | -0.61% | 22,053 | Jun 30, 2024 |
As of Jun 30 2024, Kronos Bio's biggest institutional seller is BVF INC/IL. The company sold -2.91M shares of KRON, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| GENTRUST, LLC | 0.50% | 0.02% | 295,246 | 295,246 | 100.00% | 366,105 | Jun 30, 2024 |
| INTEGRATED WEALTH CONCEPTS LLC | 0.12% | 0.00% | 71,551 | 71,551 | 100.00% | 88,723 | Jun 30, 2024 |
| PRUDENTIAL FINANCIAL INC | 0.09% | 0.00% | 55,800 | 55,800 | 100.00% | 69,192 | Jun 30, 2024 |
| 0.03% | 0.02% | 15,718 | 15,718 | 100.00% | 19,490 | Jun 30, 2024 | |
| NATIONAL BANK OF CANADA /FI/ | 0.03% | - | 15,000 | 15,000 | 100.00% | 16,800 | Jun 30, 2024 |
Kronos Bio's largest new institutional shareholder by number of shares is GENTRUST, LLC, purchased 295.25K shares, valued at $366.11K, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BVF INC/IL | - | - | - | -2,905,043 | -100.00% | - | Jun 30, 2024 |
| OMEGA FUND MANAGEMENT, LLC | - | - | - | -955,866 | -100.00% | - | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | - | - | - | -107,754 | -100.00% | - | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | - | - | - | -57,347 | -100.00% | - | Jun 30, 2024 |
| VIRTU FINANCIAL LLC | - | - | - | -54,592 | -100.00% | - | Jun 30, 2024 |
| UBS GROUP AG | - | - | - | -20,645 | -100.00% | - | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | - | - | - | -12,246 | -100.00% | - | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | - | - | - | -347 | -100.00% | - | Jun 30, 2024 |
Kronos Bio's largest sold out institutional shareholder by shares sold is BVF INC/IL, sold -2.91M shares, valued at -, as of undefined.
Kronos Bio Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| Eaton Vance Floating-Rate Income Plus Fund | 10.33% | 1,358,305 | - | - | May 31, 2021 |
| T. Rowe Price Capital Appreciation Fund, Inc. | 1.75% | 400,064,653 | - | - | Mar 31, 2024 |
| EATON VANCE SENIOR INCOME TRUST | 1.75% | 2,758,068 | - | - | Mar 31, 2024 |
| PENN SERIES FUNDS INC | 1.55% | 45,844,974 | - | - | Mar 28, 2024 |
| Pacific Global ETF Trust | 1.52% | 492,462 | - | - | Sep 30, 2021 |
| Voya INVESTORS TRUST | 1.44% | 80,131,995 | - | - | Mar 31, 2024 |
| Eaton Vance Floating-Rate 2022 Target Term Trust | 1.19% | 2,431,500 | - | - | Sep 30, 2022 |
| Eaton Vance Floating-Rate Income Trust | 1.11% | 6,282,163 | - | - | Feb 29, 2024 |
| T. Rowe Price Floating Rate Fund, Inc. | 1.11% | 40,172,804 | - | - | Feb 29, 2024 |
| EATON VANCE FLOATING RATE PORTFOLIO/MA | 1.07% | 60,617,766 | - | - | Jan 31, 2024 |
| SENIOR DEBT PORTFOLIO | 1.00% | 76,870,814 | - | - | Jan 31, 2024 |
| EATON VANCE SENIOR FLOATING RATE TRUST | 0.95% | 5,675,777 | - | - | Jan 31, 2024 |
| T. Rowe Price Institutional Income Funds, Inc. | 0.94% | 58,048,457 | - | - | Feb 29, 2024 |
| EATON VANCE VARIABLE TRUST | 0.84% | 4,911,297 | - | - | Mar 31, 2024 |
| BLACKROCK FLOATING RATE INCOME STRATEGIES FUND, INC. | 0.78% | 7,262,995 | - | - | Mar 31, 2024 |
| T. Rowe Price Credit Opportunities Fund, Inc. | 0.70% | 1,214,719 | - | - | Feb 29, 2024 |
| DELAWARE VIP TRUST | 0.68% | 2,453,505 | - | - | Mar 28, 2024 |
| EATON VANCE SPECIAL INVESTMENT TRUST | 0.56% | 1,000,000 | - | - | Mar 31, 2024 |
| NEW AMERICA HIGH INCOME FUND INC | 0.55% | 1,554,928 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS PORTFOLIO TRUST | 0.51% | 2,349,476 | - | - | Jan 31, 2024 |
| VOYA CREDIT INCOME FUND | 0.50% | 728,277 | - | - | Feb 29, 2024 |
| DELAWARE GROUP EQUITY FUNDS IV | 0.48% | 562,578 | - | - | Mar 28, 2024 |
| Nuveen Short Duration Credit Opportunities Fund | 0.48% | 1,142,487 | - | - | Apr 30, 2023 |
| T. Rowe Price High Yield Fund, Inc. | 0.40% | 32,431,576 | - | - | Feb 29, 2024 |
| BLACKROCK DEBT STRATEGIES FUND, INC. | 0.39% | 6,746,188 | - | - | Mar 31, 2024 |
| SUNAMERICA INCOME FUNDS | 0.37% | 2,295,375 | - | - | Jun 30, 2021 |
| T. Rowe Price Multi-Sector Account Portfolios, Inc. | 0.36% | 566,667 | - | - | Feb 29, 2024 |
| Eaton Vance Short Duration Diversified Income Fund | 0.36% | 1,018,729 | - | - | Jan 31, 2024 |
| NUVEEN SENIOR INCOME FUND | 0.33% | 1,226,786 | - | - | Apr 30, 2023 |
| Virtus Total Return Fund Inc. | 0.32% | 631,741 | - | - | Feb 29, 2024 |
| BlackRock Advantage SMID Cap Fund, Inc. | 0.32% | 61,073 | -11,347 | -15.67% | Mar 28, 2024 |
| BLACKROCK Ltd DURATION INCOME TRUST | 0.31% | 3,666,500 | - | - | Mar 31, 2024 |
| EATON VANCE LTD DURATION INCOME FUND | 0.31% | 6,798,396 | - | - | Mar 31, 2024 |
| Virtus Global Multi-Sector Income Fund | 0.30% | 475,299 | - | - | Feb 29, 2024 |
| Nuveen Floating Rate Income Opportunity Fund | 0.25% | 1,651,861 | - | - | Apr 30, 2023 |
| Nuveen Credit Strategies Income Fund | 0.24% | 2,910,655 | - | - | Jan 31, 2024 |
| ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST | 0.23% | 12,442,014 | - | - | Dec 31, 2023 |
| FIDELITY ADVISOR SERIES VII | 0.21% | 1,811,200 | - | - | Jan 31, 2024 |
| CORNERCAP GROUP OF FUNDS /VA/ | 0.20% | 14,607 | - | - | Sep 30, 2022 |
| AMERICAN FUNDS FUNDAMENTAL INVESTORS | 0.15% | 3,062,293 | - | - | Mar 31, 2024 |
| VIRTUS VARIABLE INSURANCE TRUST | 0.15% | 228,232 | - | - | Mar 28, 2024 |
| BRIDGEWAY FUNDS INC | 0.13% | 315,002 | 21,327 | 7.26% | Mar 28, 2024 |
| Virtus ETF Trust II | 0.12% | 162,413 | - | - | Jan 31, 2024 |
| BlackRock Health Sciences Trust II | 0.11% | 284,272 | - | - | Mar 31, 2024 |
| NUVEEN FLOATING RATE INCOME FUND | 0.10% | 2,083,586 | - | - | Jan 31, 2024 |
| Calvert Management Series | 0.09% | 975,903 | - | - | Mar 31, 2024 |
| DELAWARE GROUP ADVISER FUNDS | 0.08% | 3,226,734 | - | - | Jan 31, 2024 |
| DEUTSCHE DWS VARIABLE SERIES I | 0.08% | 27,827 | - | - | Mar 31, 2024 |
| NUVEEN INVESTMENT TRUST III | 0.08% | 1,624,405 | - | - | Feb 29, 2024 |
| AMG Funds IV | 0.07% | 197,053 | - | - | Jan 31, 2024 |
| VIRTUS OPPORTUNITIES TRUST | 0.07% | 18,363,122 | - | - | Feb 29, 2024 |
| BlackRock Health Sciences Trust | 0.06% | 16,099 | - | - | Mar 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.06% | 30,839 | - | - | Mar 31, 2024 |
| PACIFIC FUNDS SERIES TRUST | 0.06% | 17,676,029 | - | - | Mar 31, 2023 |
| VICTORY VARIABLE INSURANCE FUNDS | 0.06% | 29,800 | - | - | Mar 31, 2024 |
| ETFis Series Trust I | 0.06% | 82,208 | - | - | Jan 31, 2024 |
| VIRTUS EQUITY TRUST | 0.05% | 444,762 | - | - | Mar 28, 2024 |
| Federated Hermes MDT Series | 0.05% | 131,678 | - | - | Jan 31, 2024 |
| DELAWARE POOLED TRUST | 0.05% | 52,153 | - | - | Jan 31, 2024 |
| BlackRock Credit Strategies Fund | 0.04% | 229,798 | - | - | Mar 31, 2024 |
| T. Rowe Price New Horizons Fund, Inc. | 0.04% | 198,787 | - | - | Mar 31, 2024 |
| Invesco Senior Income Trust | 0.04% | 393,490 | - | - | Feb 29, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND | 0.04% | 789,190 | - | - | Mar 31, 2024 |
| IndexIQ ETF Trust | 0.03% | 78,961 | - | - | Jan 31, 2024 |
| T. Rowe Price Health Sciences Fund, Inc. | 0.03% | 111,866 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS GLOBAL/INTERNATIONAL FUND, INC. | 0.03% | 73,012 | - | - | Mar 31, 2024 |
| Dunham Funds | 0.03% | 2,322,588 | - | - | Jan 31, 2024 |
| T. Rowe Price Total Return Fund, Inc. | 0.03% | 252,380 | - | - | Feb 29, 2024 |
| SSGA Active Trust | 0.03% | 4,174,079 | - | - | Mar 31, 2024 |
| DELAWARE GROUP GOVERNMENT FUND | 0.03% | 139,663 | - | - | Jan 31, 2024 |
| FEDERATED HERMES CORE TRUST | 0.03% | 5,857,362 | - | - | Jan 31, 2024 |
| OPTIMUM FUND TRUST | 0.03% | 1,235,293 | - | - | Mar 28, 2024 |
| RiverNorth/DoubleLine Strategic Opportunity Fund, Inc. | 0.02% | 214,509 | - | - | Mar 31, 2023 |
| BlackRock Series Fund II, Inc. | 0.02% | 4,974 | - | - | Mar 31, 2024 |
| AMERICAN HIGH INCOME TRUST | 0.02% | 3,832,362 | - | - | Mar 31, 2024 |
| Voya FUNDS TRUST | 0.02% | 5,067,192 | - | - | Mar 31, 2024 |
| FIDELITY INCOME FUND /MA/ | 0.02% | 9,933,912 | - | - | Jan 31, 2024 |
| LORD ABBETT INVESTMENT TRUST | 0.01% | 13,584,733 | - | - | Feb 29, 2024 |
| MAINSTAY VP FUNDS TRUST | 0.01% | 1,529,173 | - | - | Mar 31, 2024 |
| VALIC Co II | 0.01% | 385,892 | - | - | Feb 28, 2021 |
| EATON VANCE MUTUAL FUNDS TRUST | 0.01% | 1,843,238 | - | - | Jan 31, 2024 |
| DELAWARE GROUP INCOME FUNDS | 0.01% | 347,000 | - | - | Jan 31, 2024 |
| BlackRock Multi-Sector Income Trust | 0.01% | 78,798 | - | - | Mar 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.01% | 65,413 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 5,952 | - | - | Mar 31, 2024 |
| FRANKLIN STRATEGIC SERIES | 0.01% | 84,158 | - | - | Jan 31, 2024 |
| SMALLCAP WORLD FUND INC | 0.01% | 600,000 | - | - | Mar 31, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.01% | 26,806 | - | - | Feb 29, 2024 |
| BLACKROCK CORPORATE HIGH YIELD FUND, INC. | 0.01% | 349,213 | - | - | Mar 31, 2024 |
| ETFis Series Trust I | 0.01% | 11,844 | - | - | Jan 31, 2024 |
| LITMAN GREGORY FUNDS TRUST | 0.01% | 480,926 | - | - | Mar 31, 2024 |
| BlackRock Funds II | 0.01% | 669,111 | - | - | Mar 31, 2024 |
| BLACKROCK CORE BOND TRUST | 0.01% | 40,791 | - | - | Mar 31, 2024 |
| FIDELITY MT VERNON STREET TRUST | 0.01% | 164,638 | - | - | Feb 29, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.01% | 365,200 | - | - | Feb 29, 2024 |
| Humankind Benefit Corp | 0.01% | 123 | - | - | Dec 31, 2023 |
| DEUTSCHE DWS SECURITIES TRUST | 0.01% | 187,973 | - | - | Jan 31, 2024 |
| Barings Funds Trust | 0.01% | 2,551,757 | - | - | Sep 30, 2021 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.01% | 1,128 | - | - | Mar 31, 2024 |
| INCOME FUND OF AMERICA | 0.00% | 1,600,860 | - | - | Jan 31, 2024 |
Kronos Bio's largest mutual fund holder by % of total assets is "Eaton Vance Floating-Rate Income Plus Fund", owning 1.36M shares, compromising 10.33% of its total assets.
Kronos Bio Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 16 | -72.41% |
| 31 Mar, 24 | 58 | -1.69% |
| 31 Dec, 23 | 59 | -7.81% |
| 30 Sep, 23 | 64 | -20.99% |
| 30 Jun, 23 | 81 | -7.95% |
| 31 Mar, 23 | 88 | -10.20% |
| 31 Dec, 22 | 98 | 5.38% |
| 30 Sep, 22 | 93 | -2.11% |
| 30 Jun, 22 | 95 | - |
| 31 Mar, 22 | 95 | 15.85% |
| 31 Dec, 21 | 82 | - |
| 30 Sep, 21 | 82 | 6.49% |
| 30 Jun, 21 | 77 | 10.00% |
| 31 Mar, 21 | 70 | -1.41% |
| 31 Dec, 20 | 71 | - |
As of 30 Jun 24, 16 institutions are holding Kronos Bio's shares, representing a decrease of -72.41% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 8,207,439 | -62.18% |
| 31 Mar, 24 | 21,700,397 | -18.86% |
| 31 Dec, 23 | 26,745,874 | -11.63% |
| 30 Sep, 23 | 30,266,227 | -5.07% |
| 30 Jun, 23 | 31,883,514 | -1.58% |
| 31 Mar, 23 | 32,396,480 | -6.08% |
| 31 Dec, 22 | 34,494,312 | -4.35% |
| 30 Sep, 22 | 36,061,549 | -2.41% |
| 30 Jun, 22 | 36,950,496 | -5.24% |
| 31 Mar, 22 | 38,994,669 | -5.03% |
| 31 Dec, 21 | 41,058,454 | 6.03% |
| 30 Sep, 21 | 38,721,806 | -2.89% |
| 30 Jun, 21 | 39,872,512 | 10.69% |
| 31 Mar, 21 | 36,020,915 | 5.59% |
| 31 Dec, 20 | 34,113,895 | - |
Kronos Bio (KRON) has 8.21M shares outstanding as of 30 Jun 24, down -62.18% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 13.79% | 0.98% |
| 31 Mar, 24 | 37.58% | 1.78% |
| 31 Dec, 23 | 46.00% | 1.65% |
| 30 Sep, 23 | 52.73% | 1.69% |
| 30 Jun, 23 | 55.79% | 1.74% |
| 31 Mar, 23 | 56.69% | 1.50% |
| 31 Dec, 22 | 61.38% | 1.50% |
| 30 Sep, 22 | 64.03% | 1.48% |
| 30 Jun, 22 | 65.85% | 1.35% |
| 31 Mar, 22 | 69.83% | 1.24% |
| 31 Dec, 21 | 74.99% | 1.51% |
| 30 Sep, 21 | 70.43% | 1.32% |
| 30 Jun, 21 | 73.15% | 1.65% |
| 31 Mar, 21 | 66.52% | 1.27% |
| 31 Dec, 20 | 72.24% | - |
As of 30 Jun 24, Kronos Bio is held by 13.79% institutional shareholders, representing a 0.98% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 6 | -70.00% |
| 31 Mar, 24 | 20 | 11.11% |
| 31 Dec, 23 | 18 | 5.88% |
| 30 Sep, 23 | 17 | -48.48% |
| 30 Jun, 23 | 33 | -10.81% |
| 31 Mar, 23 | 37 | -7.50% |
| 31 Dec, 22 | 40 | 8.11% |
| 30 Sep, 22 | 37 | -30.19% |
| 30 Jun, 22 | 53 | 26.19% |
| 31 Mar, 22 | 42 | -2.33% |
| 31 Dec, 21 | 43 | 13.16% |
| 30 Sep, 21 | 38 | -25.49% |
| 30 Jun, 21 | 51 | 112.50% |
| 31 Mar, 21 | 24 | -66.20% |
| 31 Dec, 20 | 71 | - |
6 institutional shareholders have increased their position in KRON stock as of 30 Jun 24 compared to 20 in the previous quarter (a -70.00% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 4 | -75.00% |
| 31 Mar, 24 | 16 | -5.88% |
| 31 Dec, 23 | 17 | -19.05% |
| 30 Sep, 23 | 21 | -19.23% |
| 30 Jun, 23 | 26 | 8.33% |
| 31 Mar, 23 | 24 | -22.58% |
| 31 Dec, 22 | 31 | 3.33% |
| 30 Sep, 22 | 30 | 57.89% |
| 30 Jun, 22 | 19 | -38.71% |
| 31 Mar, 22 | 31 | 106.67% |
| 31 Dec, 21 | 15 | -21.05% |
| 30 Sep, 21 | 19 | 58.33% |
| 30 Jun, 21 | 12 | -45.45% |
| 31 Mar, 21 | 22 | - |
| 31 Dec, 20 | - | - |
4 institutional shareholders have reduced their position in KRON stock as of 30 Jun 24 compared to 16 in the previous quarter (a -75.00% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 16 | -72.41% | 8,207,439 | -62.18% | 13.79% | 0.98% | 6 | -70.00% | 4 | -75.00% |
| 31 Mar, 24 | 58 | -1.69% | 21,700,397 | -18.86% | 37.58% | 1.78% | 20 | 11.11% | 16 | -5.88% |
| 31 Dec, 23 | 59 | -7.81% | 26,745,874 | -11.63% | 46.00% | 1.65% | 18 | 5.88% | 17 | -19.05% |
| 30 Sep, 23 | 64 | -20.99% | 30,266,227 | -5.07% | 52.73% | 1.69% | 17 | -48.48% | 21 | -19.23% |
| 30 Jun, 23 | 81 | -7.95% | 31,883,514 | -1.58% | 55.79% | 1.74% | 33 | -10.81% | 26 | 8.33% |
| 31 Mar, 23 | 88 | -10.20% | 32,396,480 | -6.08% | 56.69% | 1.50% | 37 | -7.50% | 24 | -22.58% |
| 31 Dec, 22 | 98 | 5.38% | 34,494,312 | -4.35% | 61.38% | 1.50% | 40 | 8.11% | 31 | 3.33% |
| 30 Sep, 22 | 93 | -2.11% | 36,061,549 | -2.41% | 64.03% | 1.48% | 37 | -30.19% | 30 | 57.89% |
| 30 Jun, 22 | 95 | - | 36,950,496 | -5.24% | 65.85% | 1.35% | 53 | 26.19% | 19 | -38.71% |
| 31 Mar, 22 | 95 | 15.85% | 38,994,669 | -5.03% | 69.83% | 1.24% | 42 | -2.33% | 31 | 106.67% |
| 31 Dec, 21 | 82 | - | 41,058,454 | 6.03% | 74.99% | 1.51% | 43 | 13.16% | 15 | -21.05% |
| 30 Sep, 21 | 82 | 6.49% | 38,721,806 | -2.89% | 70.43% | 1.32% | 38 | -25.49% | 19 | 58.33% |
| 30 Jun, 21 | 77 | 10.00% | 39,872,512 | 10.69% | 73.15% | 1.65% | 51 | 112.50% | 12 | -45.45% |
| 31 Mar, 21 | 70 | -1.41% | 36,020,915 | 5.59% | 66.52% | 1.27% | 24 | -66.20% | 22 | - |
| 31 Dec, 20 | 71 | - | 34,113,895 | - | 72.24% | - | 71 | - | - | - |
Kronos Bio Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
All Insider Owners Trades
The last insider sell of Kronos Bio's stock was made by Olek Elizabeth A on Feb 23 2024, selling 7,368 shares at $1.05 per share (valued at $7.77K). The last insider buy of KRON was made by BISCHOFBERGER NORBERT W on Jul 01 2024, buying 204,670 shares at $1.25 per share (worth $254.96K).
Kronos Bio Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | 14 | - | - |
| Q1 2024 | 2 | 25 | 8.00% |
| Q4 2023 | 3 | 2 | 150.00% |
| Q3 2023 | - | 3 | - |
| Q2 2023 | 12 | - | - |
| Q1 2023 | 9 | 3 | 300.00% |
| Q4 2022 | - | 2 | - |
| Q3 2022 | 5 | - | - |
| Q2 2022 | 17 | - | - |
| Q1 2022 | 10 | 1 | 1000.00% |
| Q4 2021 | 4 | 6 | 66.67% |
| Q3 2021 | 4 | 4 | 100.00% |
| Q2 2021 | 8 | 17 | 47.06% |
| Q1 2021 | 2 | - | - |
| Q4 2020 | 50 | 49 | 102.04% |
| Q2 2007 | 1 | 24 | 4.17% |
| Q1 2007 | 2 | 2 | 100.00% |
| Q4 2006 | 2 | 3 | 66.67% |
| Q2 2006 | 5 | 14 | 35.71% |
| Q1 2006 | 3 | 8 | 37.50% |
14 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Kronos Bio's insiders, as of Q2 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | 3 | - | - |
| Q1 2024 | - | 6 | - |
| Q4 2023 | 3 | 2 | 150.00% |
| Q3 2023 | - | 3 | - |
| Q2 2023 | - | - | - |
| Q1 2023 | - | 3 | - |
| Q4 2022 | - | 2 | - |
| Q3 2022 | - | - | - |
| Q2 2022 | 3 | - | - |
| Q1 2022 | - | - | - |
| Q4 2021 | 2 | 5 | 40.00% |
| Q3 2021 | 2 | 2 | 100.00% |
| Q2 2021 | 1 | 17 | 5.88% |
| Q1 2021 | - | - | - |
| Q4 2020 | 9 | - | - |
| Q2 2007 | - | - | - |
| Q1 2007 | - | - | - |
| Q4 2006 | - | - | - |
| Q2 2006 | - | 7 | - |
| Q1 2006 | - | 1 | - |
As of Q2 2024, Insider owners conducted 3 open market buy trades and 0 open market sell trades of Kronos Bio's stocks.
Kronos Bio Peer Ownership
| Ticker | Company |
|---|---|
| GOSS | Gossamer Bio, Inc. |
| ACHL | Achilles Therapeutics plc |
| NXTC | NextCure, Inc. |
| MRUS | Merus N.V. |
| LRMR | Larimar Therapeutics, Inc. |
| EWTX | Edgewise Therapeutics, Inc. |
| ERAS | Erasca, Inc. |
| INBX | Inhibrx Biosciences, Inc. |
| CTMX | CytomX Therapeutics, Inc. |
| SPRO | Spero Therapeutics, Inc. |
| GBIO | Generation Bio Co. |
| REPL | Replimune Group, Inc. |
| LYEL | Lyell Immunopharma, Inc. |
| CCCC | C4 Therapeutics, Inc. |
| CRNX | Crinetics Pharmaceuticals, Inc. |
| ASMB | Assembly Biosciences, Inc. |
| CYCN | Cyclerion Therapeutics, Inc. |
| ADXN | Addex Therapeutics Ltd |
| NLTX | Neurogene Inc. |
| LYRA | Lyra Therapeutics, Inc. |
| NVCT | Nuvectis Pharma, Inc. |
KRON Ownership FAQ
Who Owns Kronos Bio?
Kronos Bio is owned by institutional shareholders (13.79%), insiders (26.90%), and public (59.31%). The largest institutional shareholder of Kronos Bio is VIDA VENTURES ADVISORS, LLC (4.65% of total shares) and the top mutual fund owner is Eaton Vance Floating-Rate Income Plus Fund (10.33% of total shares).
Who are the major institutional shareholders of Kronos Bio?
Kronos Bio's major institutional shareholders are VIDA VENTURES ADVISORS, LLC, VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, PARTNERS CAPITAL INVESTMENT GROUP, LLP, and ALPHABET INC.. The top five shareholders own together 16.21% of the company's share outstanding.
How many Kronos Bio shareholders are there?
As of Jun 2024, there are 16 institutional shareholders of Kronos Bio.
What percentage of Kronos Bio is owned by VIDA VENTURES ADVISORS, LLC?
VIDA VENTURES ADVISORS, LLC owns 2.77M shares of Kronos Bio, representing 4.65% of the company's total shares outstanding, valued at $3.43M (as of Jun 2024).
What percentage of Kronos Bio is owned by VANGUARD GROUP INC?
As of Jun 2024, VANGUARD GROUP INC holds 1.92M shares of Kronos Bio (KRON), compromising 3.23% of the company, valued at $2.38M.
What percentage of Kronos Bio is owned by MILLENNIUM MANAGEMENT LLC?
MILLENNIUM MANAGEMENT LLC is the third largest holder of Kronos Bio. The company owns 1.86M of the company's shares outstanding (worth $2.3M).